BCL2 interacting protein 3 pseudogene 20 (BNIP3P20)

BCL2 interacting protein 3 pseudogene 20 (BNIP3P20) is classified as a pseudogene in the human genome[2]. Pseudogenes are non-functional segments of DNA that resemble known genes but typically do not encode functional proteins. BNIP3P20 does not produce a biologically active protein product under normal physiological conditions, and there is no evidence supporting a direct biological function, disease association, or therapeutic relevance for this pseudogene. It is related by sequence to the functional gene BNIP3, which participates in cell death and autophagy processes, but BNIP3P20 itself is not known to have a role as a therapeutic target or biomarker[2]. Key points: - BNIP3P20 is not considered a receptor, enzyme, transporter, or actionable target; it is annotated solely as a pseudogene[2]. - No disease associations, known functions, targeting drugs, mechanisms of action, or safety concerns are documented for BNIP3P20. - Some pseudogenes may have biological roles (e.g., as regulatory long non-coding RNAs), but there is currently no such evidence for BNIP3P20[2][5]. - This entry may be incorrect as a drug target, since it does not encode a functional protein and is not therapeutically actionable[2]. Summary: BNIP3P20 is a pseudogene with no confirmed biological or therapeutic relevance. Information provided here ensures future data-structuring efforts identify it appropriately as a non-target.

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 20BNIP3P20